Surmodics Announces 24-Month Data from the SWING Trial Presented at VEITHsymposium
Sundanceâ„¢ Sirolimus Drug-Coated Balloon exhibits excellent safety profile Primary patency maintained at 24 months in…
2 years ago
Alex
SS8 Networks Announces Key Executive Hire
New Senior Vice President of Global Sales Jeff Jones to Lead SS8’s Strategic Growth. MILPITAS,…
2 years ago
ReNew Successfully Commissions Its First Interstate Transmission Scheme (ISTS) Project Following Investment From Norfund and KLP
The Norwegian Climate Investment Fund, managed by Norfund, and KLP, Norway’s largest pension company, sign…
2 years ago
Alibaba Group Announces September Quarter 2023 Results
HANGZHOU, China--(BUSINESS WIRE)--$BABA #alibaba--Alibaba Group Holding Limited (NYSE: BABA and HKEX: 9988 (HKD Counter) and…
2 years ago
Radware Provides Network and Application Security for One of North America’s Busiest Airports
Combines forces with partner Wipro to bolster data center and application defenses MAHWAH, N.J., Nov.…
2 years ago
Dubai International Chamber Enhances Its Presence in Asia With Inauguration of New International Representative Office in Japan
DUBAI, United Arab Emirates--(BUSINESS WIRE)--Dubai International Chamber, one of the three chambers operating under the…
2 years ago
KYMCO Ignites Electric Revolution at EICMA 2023 with the Game-changing Ionex EV Solution
MILAN--(BUSINESS WIRE)--Building on the pinnacle of over 25 years of EV innovation, KYMCO announced three…
2 years ago
MCO Wins Financial Services and Fintech Exporter of the Year from Asia Matters
DUBLIN--(BUSINESS WIRE)--#asiarisk--Global risk and compliance technology provider MCO (MyComplianceOffice) has been named Financial Services and…
2 years ago
Faraday Unveils Enhanced Gigabit Ethernet PHY on UMC’s 28HPC+ Process
HSINCHU, Taiwan--(BUSINESS WIRE)--#GPHY--Faraday Technology Corporation (TWSE: 3035), a leader in ASIC design services and IP…
2 years ago
Exciting Progress | Gritgen Therapeutics Completed Patients Enrollment in China’s First Gene Therapy Investigator-Initiated Trial for Hemophilia A and also Achieved the First Patient Dosed in China Phase I Trial in Patients with Severe Hemophilia A
SUZHOU, China--(BUSINESS WIRE)--Gritgen Therapeutics Co., Ltd. (Gritgen), a biotechnology company focused on identifying and developing…
2 years ago